410 related articles for article (PubMed ID: 28895886)
1. Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.
Smola S
Viruses; 2017 Sep; 9(9):. PubMed ID: 28895886
[TBL] [Abstract][Full Text] [Related]
2. hrHPV E5 oncoprotein: immune evasion and related immunotherapies.
de Freitas AC; de Oliveira THA; Barros MR; Venuti A
J Exp Clin Cancer Res; 2017 May; 36(1):71. PubMed ID: 28545552
[TBL] [Abstract][Full Text] [Related]
3. The role of interleukin 10 in human papilloma virus infection and progression to cervical carcinoma.
Berti FCB; Pereira APL; Cebinelli GCM; Trugilo KP; Brajão de Oliveira K
Cytokine Growth Factor Rev; 2017 Apr; 34():1-13. PubMed ID: 28365229
[TBL] [Abstract][Full Text] [Related]
4. Immune concept of human papillomaviruses and related antigens in local cancer milieu of human cervical neoplasia.
Sheu BC; Chang WC; Lin HH; Chow SN; Huang SC
J Obstet Gynaecol Res; 2007 Apr; 33(2):103-13. PubMed ID: 17441881
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus: often harmless but in some cases carcinogenic.
Prescrire Int; 2007 Jun; 16(89):115-9. PubMed ID: 17585425
[TBL] [Abstract][Full Text] [Related]
6. Immune responses against human papillomavirus (HPV) infection and evasion of host defense in cervical cancer.
Sasagawa T; Takagi H; Makinoda S
J Infect Chemother; 2012 Dec; 18(6):807-15. PubMed ID: 23117294
[TBL] [Abstract][Full Text] [Related]
7. Papillomavirus-associated squamous skin cancers following transplant immunosuppression: one Notch closer to control.
Connolly K; Manders P; Earls P; Epstein RJ
Cancer Treat Rev; 2014 Mar; 40(2):205-14. PubMed ID: 24051018
[TBL] [Abstract][Full Text] [Related]
8. [Cutaneous squamous cell carcinoma and human papillomavirus].
Corbalán-Vélez R; Ruiz-Maciá JA; Brufau C; Carapeto FJ
Actas Dermosifiliogr; 2007 Nov; 98(9):583-93. PubMed ID: 17961447
[TBL] [Abstract][Full Text] [Related]
9. The role of human papilloma virus (HPV) infection in non-anogenital cancer and the promise of immunotherapy: a review.
Cobos C; Figueroa JA; Mirandola L; Colombo M; Summers G; Figueroa A; Aulakh A; Konala V; Verma R; Riaz J; Wade R; Saadeh C; Rahman RL; Pandey A; Radhi S; Nguyen DD; Jenkins M; Chiriva-Internati M; Cobos E
Int Rev Immunol; 2014 Oct; 33(5):383-401. PubMed ID: 24811210
[TBL] [Abstract][Full Text] [Related]
10. Biology and pathological associations of the human papillomaviruses: a review.
Cheah PL; Looi LM
Malays J Pathol; 1998 Jun; 20(1):1-10. PubMed ID: 10879257
[TBL] [Abstract][Full Text] [Related]
11. [Non-melanoma skin cancers and human papillomavirus].
Aubin F; Humbey O; Guérrini JS; Mougin C; Laurent R
Ann Dermatol Venereol; 2003 Dec; 130(12 Pt 1):1131-8. PubMed ID: 14724516
[TBL] [Abstract][Full Text] [Related]
12. Regulation of immune responses to HPV infection and during HPV-directed immunotherapy.
Bhat P; Mattarollo SR; Gosmann C; Frazer IH; Leggatt GR
Immunol Rev; 2011 Jan; 239(1):85-98. PubMed ID: 21198666
[TBL] [Abstract][Full Text] [Related]
13. Viral Modulation of TLRs and Cytokines and the Related Immunotherapies for HPV-Associated Cancers.
Barros MR; de Oliveira THA; de Melo CML; Venuti A; de Freitas AC
J Immunol Res; 2018; 2018():2912671. PubMed ID: 29854832
[TBL] [Abstract][Full Text] [Related]
14. Immune deviation and cervical carcinogenesis.
Smola S
Papillomavirus Res; 2019 Jun; 7():164-167. PubMed ID: 30980967
[TBL] [Abstract][Full Text] [Related]
15. HPV post-infection microenvironment and cervical cancer.
Yuan Y; Cai X; Shen F; Ma F
Cancer Lett; 2021 Jan; 497():243-254. PubMed ID: 33122098
[TBL] [Abstract][Full Text] [Related]
16. Circulating human papillomavirus type 16 specific T-cells are associated with HLA Class I expression on tumor cells, but not related to the amount of viral oncogene transcripts.
de Boer MA; Jordanova ES; van Poelgeest MI; van den Akker BE; van der Burg SH; Kenter GG; Fleuren GJ
Int J Cancer; 2007 Dec; 121(12):2711-5. PubMed ID: 17724722
[TBL] [Abstract][Full Text] [Related]
17. Cross-talk of cutaneous beta human papillomaviruses and the immune system: determinants of disease penetrance.
Venuti A; Lohse S; Tommasino M; Smola S
Philos Trans R Soc Lond B Biol Sci; 2019 May; 374(1773):20180287. PubMed ID: 30955489
[TBL] [Abstract][Full Text] [Related]
18. Activation of interleukin-6/signal transducer and activator of transcription 3 by human papillomavirus early proteins 6 induces fibroblast senescence to promote cervical tumourigenesis through autocrine and paracrine pathways in tumour microenvironment.
Ren C; Cheng X; Lu B; Yang G
Eur J Cancer; 2013 Dec; 49(18):3889-99. PubMed ID: 23953057
[TBL] [Abstract][Full Text] [Related]
19. [Papillomavirus infections and cervical tumorigenesis].
Kiyono T
Gan To Kagaku Ryoho; 2010 Feb; 37(2):227-31. PubMed ID: 20235389
[No Abstract] [Full Text] [Related]
20. Human Papillomavirus Infection and p16 Expression in Extragenital/Extraungual Bowen Disease in Immunocompromised Patients.
Švajdler M; Mezencev R; Kašpírková J; Kacerovská D; Kazakov DV; Ondič O; Michal M
Am J Dermatopathol; 2016 Oct; 38(10):751-7. PubMed ID: 26913849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]